Macquarie Group LTD Ionis Pharmaceuticals Inc Transaction History

Macquarie Group LTD

$79.1 Billion
Q2 2025

A detailed history of Macquarie Group LTD transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Macquarie Group LTD holds 1,434,073 shares of IONS stock, worth $106 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,434,073

Previous 1,667,194 13.98%

Holding current value

$106 Million

Previous $50.3 Million 12.65%

% of portfolio

0.07%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	SELL	$25.51 - $40.0 $5.95 Million - $9.32 Million	-233,121 Reduced 13.98%	1,434,073 $56.7 Million
Q1 2025 May 15, 2025	SELL	$30.17 - $34.97 $3.09 Million - $3.59 Million	-102,549 Reduced 5.79%	1,667,194 $50.3 Million
Q4 2024 Feb 14, 2025	SELL	$33.73 - $40.36 $3.38 Million - $4.04 Million	-100,063 Reduced 5.35%	1,769,743 $61.9 Million
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $154,711 - $200,283	-3,862 Reduced 0.21%	1,869,806 $74.9 Million
Q2 2024 Aug 09, 2024	SELL	$36.45 - $47.7 $48.4 Million - $63.3 Million	-1,326,910 Reduced 41.46%	1,873,668 $89.3 Million
Q1 2024 May 14, 2024	BUY	$42.03 - $53.55 $4.72 Million - $6.02 Million	112,343 Added 3.64%	3,200,578 $139 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $6.61 Million - $7.86 Million	152,311 Added 5.19%	3,088,235 $156 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $55.3 Million - $67.7 Million	1,437,042 Added 95.87%	2,935,924 $133 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $172,920 - $215,740	4,979 Added 0.33%	1,498,882 $61.5 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $74,413 - $91,299	2,216 Added 0.15%	1,493,903 $53.4 Million
Q4 2022 Feb 21, 2023	BUY	$37.12 - $46.52 $24.4 Million - $30.6 Million	657,646 Added 78.85%	1,491,687 $56.3 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $29.3 Million - $39 Million	800,773 Added 2407.04%	834,041 $37 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $40,018 - $54,266	1,262 Added 3.94%	33,268 $1.23 Million
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $16,224 - $20,112	-543 Reduced 1.67%	32,006 $1.19 Million
Q4 2021 Feb 11, 2022	BUY	$25.61 - $35.1 $3,098 - $4,247	121 Added 0.37%	32,549 $991,000
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $68,078 - $93,129	1,971 Added 6.47%	32,428 $1.29 Million
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $269,683 - $404,620	6,344 Added 26.31%	30,457 $1.37 Million
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $15,764 - $20,973	348 Added 1.46%	24,113 $1.36 Million
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $10,486 - $13,911	-221 Reduced 0.92%	23,765 $1.13 Million
Q2 2020 Aug 11, 2020	SELL	$46.85 - $61.05 $309,959 - $403,906	-6,616 Reduced 21.62%	23,986 $1.41 Million
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $105,622 - $160,972	2,539 Added 9.05%	30,602 $1.45 Million
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $400,644 - $485,608	7,440 Added 36.08%	28,063 $1.7 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $153,910 - $188,022	2,606 Added 14.46%	20,623 $1.24 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $30,486 - $42,294	491 Added 2.8%	18,017 $1.16 Million
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $342,021 - $524,601	-6,463 Reduced 26.94%	17,526 $1.42 Million
Q4 2018 Feb 15, 2019	BUY	$43.37 - $59.54 $27,019 - $37,093	623 Added 2.67%	23,989 $1.3 Million
Q3 2018 Nov 15, 2018	SELL	$42.88 - $53.7 $273,445 - $342,444	-6,377 Reduced 21.44%	23,366 $1.21 Million
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $1.21 Million - $1.51 Million	29,743 New	29,743 $1.24 Million

Others Institutions Holding IONS

# of Institutions

432

Shares Held

149M

Call Options Held

1.72M

Put Options Held

722K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $10.5B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Ionis Pharmaceuticals Inc Transaction History